Document:

EXECUTION COPY

  

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT
(“Agreement”) is made and entered into as of the __ day of August, 2013, by and between the Grilled Cheese Truck Inc.,
a Nevada Corporation (“the Company”), and Deepak R. Devaraj (“Employee”).

 

		1.	Term of Employment.The Company hereby employs
Employee, and Employee hereby agrees to serve the Company, under and subject to all of the terms, conditions and provisions of
this Agreement for a period of three (3) years from the date hereof.

 

		1.1	Employee shall serve in the capacity of Director of Business Development of the Company, or to
serve in such other executive capacity with the Company as the Company’s board of directors (the “Board”) may
from time to time designate, provided such assignment is consistent with Employee’s level of experience and expertise. This
Agreement may be extended for up to three additional years upon mutual written agreement of the Company and the Employee. Company
shall give Employee six months advance notice of its intentions regarding such extension. In the performance of his duties
and the exercise of his discretion, Employee shall report only to the Board of Directors. Employee's duties shall be designated
by the Board and shall be subject to such policies and directions as may be established or given by the Board from time to time.

 

		1.2	Employee shall be entitled to become elected to the Board of Directors of the Company for an initial
term of one year.

 

Devotion of Time to Company
Business. Employee shall devote substantially all of his productive time, ability and attention to the business of the Company
during the term of this Agreement. Employee shall not, without the prior written consent of the Board, directly or indirectly render
any services of a business, commercial or professional nature to any other person or organization, whether for compensation or
otherwise, which may compete or conflict with the Company’s business or with Employee’s duties to the Company.

 

		2.	Compensation.

 

		2.1	Base Salary. For all services rendered by Employee under this Agreement, the Company shall
pay Employee a base salary (“Base Salary”) payable semi-monthly, at the rate of $0.00 per month.

 

		(a)	Payment for Other Work. In addition to the amount specified in Section 2.l, the Company
shall pay Employee, on a case-by-case basis and on terms and compensation to be negotiated separate from this Agreement and evidenced
in a separate agreement, for Employee’s role with respect to any Business Development or any Management Support activities
as may be requested or desired by the Company.

 

		(b)	Payment for Licensing Referrals. For any Business Development whereby Employee introduces
a prospect to the Company that enters into a Licensing Agreement with the Company, the Company agrees to pay Employee compensation
of as described in a Sliding Yearly Scale: 5% of the license or franchise fee on a transaction for the first year, 4.5% for the
second year, 4% for the third year, 3.5% for the fourth year, 3% for the fifth year, 2.5% thereafter for the term of the licensing
fee.

 

    	 

    	 

    

 

		2.2	In the sole discretion of the Board of Directors (with Employee not voting and not present during
the deliberations of the Board of Directors), the Company may award discretionary additional cash bonuses to Employee for significant
accomplishments that produce material benefits for the Company. In considering whether to award any such discretionary bonus, the
Board shall take into account the size such discretionary bonus, the size and nature of the matter, the extra efforts of Employee,
the difficulty of attaining the result that he has attained, the time required to accomplish the result, the merits and benefits
to the Company, the effect on the market price of the Company's stock, and such other factors as the Board may deem appropriate.
The Board shall not be required to award any such additional bonus, and neither the Company nor the directors shall have any liability
to Employee for any action or non-action with respect to any such discretionary additional bonus under this Section 2.2.

 

		2.3	In addition to his Base Salary and cash bonuses, if any, the Employee shall receive, within thirty
(30) days from the effective date of this Agreement, the following fully vested options under the Company’s stock option
plan:

 

		(a)	Incentive stock options to purchase 250,000 shares of the Company's common stock at $2.00 per share;

 

		(b)	Incentive stock options to purchase an additional 250,000 shares of the Company’s common
stock at $3.00 per share;

 

		(c)	Incentive stock options to purchase an additional 250,000 shares of the Company’s common
stock at $4.00 per share;

 

		(d)	Incentive stock options to purchase an additional 250,000 shares of the Company’s common
stock at $5.00 per share.

 

Such options shall be granted
under the Company's stock option plan and shall be evidenced by a stock option agreement containing terms and conditions satisfactory
to the Board of Directors (with Employee not voting and not present during the deliberations of the Board of Directors).

 

		3.	Benefits.

 

		3.1	It is anticipated that Employee will spend considerable amount of time traveling on behalf of the
Company in the discharge of his duties. During the period of his employment hereunder, a company credit card will be available
for reasonable business, travel and entertainment expenses incurred in accordance with Company policy on behalf of the Company
in connection with his employment. Additional out of pocket expenses will be reimbursed when necessary. Employee will be required
to submit appropriate expense reports for approval by signature of the Chief Financial Officer as a condition of reimbursement
of such expenses. Frequent traveler bonus points thus earned will accrue to the personal account of Employee as additional compensation.

 

		3.2	In lieu of a company provided automobile, the Company will pay an expense allowance for an automobile
owned by Employee, in an amount of $0 per month.

 

    	 

    	 

    

 

		3.3	Employee shall be entitled to one (1) week vacation upon completion of every three (3) full months
of employment under this Agreement. To the extent that Employee does not take vacation; Employee may accumulate such vacation time
throughout the term of this Agreement up to a maximum of six (6) weeks. Upon the termination of this Agreement, with or without
Cause, and to the extent that Employee has accumulated vacation time up to the maximum allowed, the Company shall pay to Employee,
in addition to all other consideration due Employee in the event of termination herein, the full value of such accumulated vacation
time commensurate with the Base Salary provided above.

 

		3.4	The Company acknowledges that Employee maintain his principal residence in Dallas, Texas. Employee
shall not be required to move his principle residence. The Company will provide Employee with reimbursement for housing in areas
outside of Dallas, Texas at such times as Employees determines necessary or appropriate of up to $3,000.00 per month. If Employee
agrees to change his permanent residence at the request of the Company, the Company shall pay reasonable relocation costs, including
but not limited to moving expenses.

 

		4.	Authority. So long as Employee serves as Director of Business Development of the Company
under this Agreement he shall have the authority specified in the By-Laws of the Company, except that he shall not proceed with
any matters, or permit the Company to take any actions, which are prohibited by, or are in conflict with, resolutions or guidelines
adopted by the Board of Directors; and under no circumstances shall Employee, without express prior authorization by the Board
of Directors, make any change in capital structure or issue any stock of the Company, incur additional debt, change the Company's
lines of business, or make any other material changes to the corporate structure and provided further that any payments or checks
in excess of $75,000.00 shall require the signature of two persons designated by resolution of the Board of Directors.

 

		5.	Termination. This Agreement shall terminate in advance of the time specified in Section
1 above (and except as provided herein, Employee shall have no right to receive any compensation due and payable to him or his
estate at the time of such termination) under any of the following circumstances:

 

		5.1	Upon the death of Employee during the term of this Agreement, the Company shall pay to the estate
of Employee Base Salary, bonuses, and any other compensation accrued or earned by Employee as of the date of death, plus an amount
equal to (a) six (6) months of Base Salary or (b) the Base Salary that Employee would have received up to the expiration of the
Agreement, whichever period is less.

 

		5.2	In the event that Employee shall become either physically or mentally incapacitated so as to not
be capable of performing his duties as required hereunder, and if such incapacity shall continue for a period of three months consecutively,
the Company may, at its option, terminate this Agreement by written notice to Employee at that time or at any time thereafter while
such incapacity continues. In case of termination under this Section, Employee or his estate shall be entitled to receive Base
Salary, bonuses and any other compensation accrued or earned as of or to the date of termination, and for six months following
such termination or until the expiration of the term of this Agreement, whichever is earlier. In addition, the Company shall permit
Employee to participate in Company's medical, dental, and long term disability and long term care insurance plans, if any, at Employee's
cost, for a period of one (1) year following termination herein and to the extent permitted by law.

 

    	 

    	 

    

 

		5.3	By Employee, if the Company shall have materially breached any of the provisions of this Agreement;
provided, that the Company shall pay Employee his Base Salary through the remaining term of this Agreement.

 

		5.4	By the Company for Cause. The term “Cause” used in this Section 5 means that Employee,
(i) after repeated written notices and warnings and. a reasonable opportunity for cure, fails to perform his reasonably assigned
duties as reasonably determined by the Board of Directors, (ii) is convicted of any felony involving moral turpitude, or (iii)
commits any intentionally dishonest or fraudulent act which materially damages or may damage the Company's business or reputation.
If the Company terminates Employee for Cause, no payments or benefits under this Agreement shall become payable after the date
of Employee’s termination.

 

		6.	Loyalty. Non-Competition and Confidentiality.

 

		6.1	Non-Competition. Employee agrees and covenants that, except for the benefit of the Company
(and or successor, parent or subsidiary) during the Non-Competition Period (as defined in Section 6.2 he will not engage, directly
or indirectly (whether as an officer, director, consultant, employee, representative, agent, partner, owner, stockholder, or otherwise)
in any business engaged in by the Company in the Non-Competition Area (as defined in Section 6.3 nor will Employee compete against
the Company for any transaction or corporate opportunity which the Company has or may have an interest in pursuing. It is the parties'
express intention that if a court of competent jurisdiction finds or holds the provisions of this Section 6 to be excessively broad
as to time, duration, geographical scope, activity or subject, this Section 6 shall then be construed by limiting or reducing it
so as to comport with then applicable law.

 

		6.2	Non-Competition Period. As used herein, the “Non-Competition Period” means the
period beginning on the date hereof and ending on a date which is three years from the date of this Agreement; provided however,
that if Employee’s employment is terminated by the Company without Cause, the Non-competition Period shall end on the date
of such termination.

 

		6.3	Non-Competition Area. As used herein, the term “Non-Competition Area” means
anywhere within the State of Texas during the term of this Agreement.

 

		6.4	Other Employees. Employee agrees that during the Non-Competition Period he shall not, directly
or indirectly, for his own account or as agent, servant or employee of any business entity, engage, hire or offer to hire or entice
away or in any other manner persuade any officer, employee or agent of the Company or any subsidiary to discontinue his relationship
with the Company .or any subsidiary .of the Company.

 

		6.5	Confidentiality. Employee acknowledges that he has learned and will learn Confidential Information,
as defined in Section 6.6, relating to the business of the Company. Employee agrees that he will not, except in the normal and
proper course of his duties, disclose or use, either during the Non-Competition Period or subsequently thereto, any such Confidential
Information without prior written approval of the Board of Directors of the Company.

 

    	 

    	 

    

 

		6.6	Confidential Information. “Confidential Information” shall mean contractual
arrangements, plans, locations, strategies, tactics, potential acquisitions or business combinations or joint venture possibilities,
policies and negotiations; marketing information, including sales, purchasing and inventory plans, strategies, tactics, methods,
customers, advertising, promotion or market research data; financial information, including operating results and statistics, costs
and performance data, projections, forecasts, investors, and holdings; and .operational information, including trade secrets, secret
formulae, control and inspection practices, accounting systems and controls, computer programs and data, personnel lists, resumes,
personal data, organizational structure and performance evaluations and .other information of the company which derives economic
value from not being generally known to the public or the company’s competitors. Confidential Information does not include
skills, knowledge and experience acquired by Employee during his employment with any prior employer.

 

		6.7	Corporate Documents. Employee agrees that all documents of any nature pertaining to activities
of the Company or to any of the Company’s Confidential Information in his possession now or at any time during the Non-Competition
Period, including, without limitation, memoranda, notebooks, notes, computer records, disks, electronic information data sheets,
records and blueprints, are and shall be the property of the Company and that they and all copies of them shall be surrendered
to the Company whenever requested by the Board of Directors from time to time during the Non-Competition Period and thereafter
and with or without request upon termination of Employee’s employment with the Company.

 

		7.	Equitable Remedies. In the event .of a breach by Employee of any of the provisions of the
Section 6, the Company, in addition to any other remedies it may have, shall be entitled to an injunction restraining Employee
from doing or continuing to do any such act in violation of the Section 6.

 

		8.	Attorney Fees. The successful party in any litigation relating to matters covered by this
Agreement shall be entitled to an award of reasonable attorneys’ fees in such action.

 

		9.	Assignment. Neither this Agreement nor any of the rights or obligations of either party
hereunder shall be assignable by either Employee or the Company, except that this Agreement shall be assignable by the Company
to and shall inure to the benefit of and be binding upon (i) any successor of the Company by way of merger, consolidation or transfer
of all or substantially all of the assets of the Company to an entity other than any parent, subsidiary or affiliate of the Company
and (ii) any parent, subsidiary or affiliate of the Company to which the Company may transfer its rights hereunder.

 

		10.	Binding Effect. The terms, conditions, covenants and agreements set forth herein shall inure
to the benefit of, and be binding upon, the heirs, administrators, successors and assigns of each of the panics hereto, and upon
any corporation, entity or person with which the Company may become merged, consolidated, combined or otherwise affiliated.

 

		11.	Amendment. This Agreement may not be altered or modified except by further written agreement
by the parties.

 

		12.	Notices. Any notice required or permitted to be given under this Agreement by one party
to the other shall be sufficient if given or confirmed in writing and delivered personally or mailed by first class mail, registered
or certified, return receipt requested (if mailed from the Untied States), postage prepaid, or sent by facsimile transmission,
addressed to such party as respectively indicated below or as otherwise designated by such party in writing.

 

If to the
Company, to:

 

Robert Lee,
Chairman

 

    	 

    	 

    

 

641 Lexington
Ave, Suite 1523

New York, NY
10022

 

If to Employee,
to:

 

Deepak R. Devaraj

4700 W. Hanover

Dallas, TX
75209

 

		13.	Survivorship.  Except as otherwise set forth in this Agreement, the respective
rights and obligations of the Employee and the Company hereunder shall survive any termination of the Employee’s employment.

 

		14.	Waiver.  The waiver by either party of a breach of any provision of this Agreement
shall not be construed as a waiver of any subsequent breach.  The failure of a party to insist upon strict adherence
to any provision of this Agreement on one or more occasions shall not be considered a waiver or deprive that party of the right
thereafter to insist upon strict adherence to that provision or any other provision of this Agreement.  Any waiver must
be in writing and signed by the Employee and the Company.

 

		15.	New York Law. This Agreement is being executed and delivered and is intended to be performed
and shall be governed by and construed in accordance with the laws of the State of New York.

 

		16.	Indemnification.

 

		16.1	The Company agrees that if the Employee is
made a party, or is threatened to be made a party, to any action, suit or proceeding, whether civil, criminal, administrative or
investigative (a “Proceeding”), by reason of the fact that he is or was a director, officer or employee of the Company
or is or was serving at the request of the Company as a director, officer, member, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, including service with respect to employee benefit plans, the Employee shall be indemnified
and held harmless by the Company to the fullest extent legally permitted or authorized by the Company’s articles of incorporation,
bylaws or resolutions of the Board against all cost, expense, liability and loss (including, without limitation, attorneys’
fees, judgments, fines, ERISA excise taxes or other liabilities or penalties and amounts paid or to be paid in settlement) reasonably
incurred or suffered by the Employee in connection therewith, and such indemnification shall continue as to the Employee even if
he has ceased to be a director, member, employee or agent of the Company or other entity and shall inure to the benefit of the
Employee’s heirs, executors and administrators.  The Company shall advance to the Employee all costs and expenses
incurred by him in connection with a Proceeding within a reasonable time after submission of reasonable documentation of such costs
and expenses.  Such request shall include an undertaking by the Employee to repay the amount of such advance if it shall
ultimately be determined that he is not entitled by law to be indemnified against such costs and expenses; provided that the amount
of such obligation to repay shall be limited to the after-tax amount of any such advance except to the extent the Employee is able
to offset such taxes incurred on the advance by the tax benefit, if any, attributable to a deduction realized by him for the repayment.
The Company shall not be responsible under this Agreement to indemnify the Employee for any costs or expenses incurred by
the Employee: (i) on account of acts which, at the time taken, were known or believed by the Employee to be clearly in conflict
with the Company’s best interests or (ii) in a Proceeding by right or in the right of the Company to procure a judgment in
its favor against the Employee if Employee acted without good faith.

 

    	 

    	 

    

 

		16.2	Neither the failure of the Company (including
its Board, independent legal counsel or stockholders) to have made a determination prior to the commencement of any Proceeding
concerning payment of amounts claimed by the Employee under Section 16.1 above that indemnification of the Employee is proper because
he has met the applicable standard of conduct, nor a determination by the Company (including its Board, independent legal counsel
or stockholders) that the Employee has not met such applicable standard of conduct, shall create a presumption in any judicial
proceeding that the Employee has not met the applicable standard of conduct.

 

		16.3	The Company agrees to continue and maintain
director’s and officer’s liability insurance policy covering the Employee, until such time as actions against the Employee
are no longer permitted by law, with terms and conditions no less favorable than the most favorable coverage then applying to any
other senior level executive officer or director of the Company.

 

17.          Board Approval. This Agreement
is subject to the Company Board of Directors approval.

 

18.          Severability.  The
provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect
the validity or enforceability of the other provisions hereof.

  

19.          Entire Agreement. This
Agreement constitutes the entire agreement between the Company and the Employee and supersedes all prior agreements, understandings
and arrangements, oral or written, between the parties with respect to the subject matter hereof.  This Agreement may
be executed in one or more counterparts.

 

    	 

    	 

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the date and year first above written.

 

	 	THE GRILLED CHEESE TRUCK, INC.
	 	 
	 	By:	 
	 	 	 
	 	Name:	Robert Y. Lee
	 	 	 
	 	Title:	Chairman of the Board of Directors
	 	 
	 	EMPLOYEE
	 	 
	 	 
	 	Deepak DevarajEXHIBIT
4.1 

 

NEITHER THIS CONVERTIBLE PROMISSORY
NOTE NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”) OR THE SECURITIES LAWS OF ANY STATE. NO SALE OR DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE
144 UNDER THE ACT OR AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN APPLICABLE EXEMPTION THEREFROM.

 

CONVERTIBLE PROMISSORY NOTE

 

	Purchaser:	 	 	Issuance Date:	 
	Principal Amount:	$	 	Maturity Date:	 

 

For value received,
Vertical Health Solutions, Inc. d/b/a OnPoint Medical Diagnostics, a Florida corporation (“Company”) hereby promises
to pay the Purchaser the Principal Amount (as set forth above), plus any accrued but unpaid Interest (as defined below). This Note
is one of a series of Notes issued to certain investors (this Note, together with such other Notes shall be collectively referenced
to as the “Notes”) by Company in an aggregate principal amount of One Million Dollars ($1,000,000).

1.                 
Interest; Payments.

1.1             
Simple interest on the unpaid Principal Amount shall accrue at the rate of 6% per annum (“Interest”)
and will begin to accrue upon the Issuance Date. Interest shall be calculated based on a 365-day year and charged for the actual
number of days elapsed.

1.2             
All payments of the Principal Amount and Interest shall be in lawful money of the United States
of America. All payments shall be applied first to accrued Interest, and thereafter to the Principal Amount. If any payments on
this Note become due on a Saturday, Sunday or a public holiday under the laws of the State of Minnesota, such payment shall be
made on the next succeeding business day and such extension of time shall be included in computing Interest in connection with
such payment.

2.                 
Conversion.

2.1             
Mandatory Conversion. 

(a)               
Qualified Financing. If, at any time prior to the repayment or conversion of this Note
(as provided herein), Company issues and sells shares of its capital stock to investors (the “Investors”) in a Qualified
Financing (as defined herein), then the outstanding principal balance of this Note and accrued but unpaid Interest thereon shall
convert into the capital stock sold at the first closing of the Qualified Financing at a conversion price equal to the lesser of
(i) the price per share (or conversion price) paid by the Investors purchasing such stock at such first closing of the Qualified
Financing or (ii) $0.25 per share. For purposes of this Note the term “Qualified Financing” shall mean the sale of
the Company’s capital stock, in one transaction or series of related transactions after the date hereof, for an aggregate
sales price of at least Two Million Dollars ($2,000,000), paid in cash and/or by conversion of indebtedness of the Company, excluding
conversion of the Notes. Any such conversion with regard to this Note shall be implemented only if all of the Notes are simultaneously
being converted. 

(b)              
Change of Control. In the event of a “Change in Control” (as defined below)
of the Company prior to the repayment or conversion of this Note (as provided herein), all outstanding principal and unpaid accrued
Interest

    	 

    	 

    

due on this Note shall convert into that number of shares (the “Shares”) of common stock, par value
$0.001 per share, of the Company (“Common Stock”) as is determined by dividing such outstanding Principal Amount and
accrued Interest by $0.25 per share (adjusted to reflect subsequent stock dividends, stock splits, combinations or recapitalizations)
(the “Conversion Price”), or such other securities on terms and conditions agreed upon by the Company and Requisite
Purchasers (as defined below). For purposes of this Note, a “Change in Control” shall be deemed to be occasioned by,
and to include, (i) the acquisition of the Company by another entity by means of any transaction (including, without limitation,
any stock acquisition, reorganization, merger or consolidation), or (ii) a sale of all or substantially all of the assets of the
Company (including, for purposes of this section, intellectual property rights which, in the aggregate, constitute substantially
all of the Company’s material assets). Notwithstanding the above, a preferred stock financing or reincorporation transaction
for purposes of changing the Company’s state of incorporation shall not be deemed a Change in Control transaction. Any such
conversion with regard to this Note shall be implemented only if all of the Notes are simultaneously being converted.

(c)               
Financial Milestone. If, at any time prior to the repayment or conversion of this Note
(as provided herein), the Company earns Five Hundred Thousand Dollars ($500,000) or more in gross revenue for any fiscal quarter,
as reflected in the Company’s Quarterly Report on Form 10-Q or Annual Report on Form 10-K, as applicable (the “SEC
Report”), any outstanding Principal Amount of and all accrued Interest under this Note shall automatically convert within
one (1) business day of the filing of the SEC Report, into that number of Shares as is determined by dividing such outstanding
Principal Amount and accrued Interest by the Conversion Price. Any such conversion with regard to this Note shall be implemented
only if all of the Notes are simultaneously being converted. 

(d)              
Maturity. On the Maturity Date of this Note, all outstanding principal and unpaid accrued
Interest due on this Note shall convert into that number of shares of common stock, par value $0.001 per share, of the Company
(“Common Stock”) as is determined by dividing such outstanding Principal Amount and Accrued Interest by $0.25 per share.

2.2             
Optional Conversion. At any time on or prior to the Maturity Date, all or any
portion of the outstanding Principal Amount of and all accrued Interest under this Note may be converted, at the option of the
Purchaser, into that number of Shares as is determined by dividing such outstanding Principal Amount and accrued Interest by the
Conversion Price. To convert this Note, the Purchase shall deliver written notice substantially in the form attached to this Note
(the “Conversion Notice”), to the Company at its address as set forth herein. The date upon which the
conversion shall be effective (the “Conversion Date”) shall be deemed to be the date set forth in the
Conversion Notice.

2.3             
Fraction Shares. No fractional shares of Company’s capital stock will be issued
upon conversion of this Note. In lieu of any fractional share to which Purchaser would otherwise be entitled, Company will pay
to Purchaser in cash the amount of the unconverted Principal Amount and Interest balance of this Note that would otherwise be converted
into such fractional share. 

2.4             
Effect of Conversion. Upon conversion of this Note pursuant to this Section 2,
Purchaser shall surrender this Note, duly endorsed, at the principal offices of Company. Upon conversion of this Note pursuant
to Section 2, this Note will be deemed converted on the date that is immediately prior to the close of business on the date
of the surrender of this Note. At its expense, Company will, as soon as practicable thereafter, issue and deliver to Purchaser,
at Purchaser’s address as set forth on the signature page hereto or such other address requested by Purchaser, a certificate
or certificates for the number of shares to which Purchaser is entitled upon such conversion (bearing such legends as are required
by the Purchase Agreement, any other agreement entered into in connection with the any such conversion or applicable state and
federal securities laws), together with a replacement Note (if any Principal Amount is not converted) and any other securities
and property to which Purchaser is entitled upon such conversion under the terms of this Note, including a check payable to Purchaser
for any cash amounts payable as a result of any fractional shares as described herein.

3.                 
Warrant. In consideration of and in conjunction with purchase of this Note,
the Company shall simultaneously issue the Purchaser a warrant, substantially in the form attached hereto as Exhibit A (each,
a “Warrant”), to purchase a number of shares of Common Stock (the “Warrant Shares”) equal to the Principal
Amount (one Warrant Share for each One Dollar ($1.00) of Principal Amount). The Warrant shall be exercisable for a period of ten
years from the Issuance Date and shall have an exercise price of $1.25 per share.

    	 

    	 

    

4.                 
Representations And Warranties Of The Purchaser.

4.1             
Purchase for Own Account. The Purchaser understands that the Note, the Shares, the
Warrants and the Warrant Shares (collectively, the “Securities”), have not been registered under the Act on the basis
that no distribution or public offering of the stock of the Company is to be effected. The Purchaser realizes that the basis for
the exemption may not be present if, notwithstanding its representations, the Purchaser has a present intention of acquiring the
Securities for a fixed or determinable period in the future, selling (in connection with a distribution or otherwise), granting
any participation in, or otherwise distributing the Securities. The Purchaser represents that it is acquiring the Securities solely
for its own account and beneficial interest for investment and not for sale or with a view to distribution of the Securities or
any part thereof, has no present intention of selling (in connection with a distribution or otherwise), granting any participation
in, or otherwise distributing the same, and does not presently have reason to anticipate a change in such intention.

4.2             
Information and Sophistication. The Purchaser hereby: (i) acknowledges that it has
received all the information it has requested from the Company and it considers necessary or appropriate for deciding whether to
acquire the Securities, (ii) represents that it has had an opportunity to ask questions and receive answers from the Company regarding
the terms and conditions of the offering of the Securities and to obtain any additional information necessary to verify the accuracy
of the information given the Purchaser and (iii) further represents that it has such knowledge and experience in financial and
business matters that it is capable of evaluating the merits and risk of this investment.

4.3             
Ability to Bear Economic Risk. The Purchaser acknowledges that investment in the Securities
involves a high degree of risk, and represents that it is able, without materially impairing its financial condition, to hold the
Securities for an indefinite period of time and to suffer a complete loss of its investment.

4.4             
Rule 144. The Purchaser is aware that none of the Securities may be sold pursuant to
Rule 144 adopted under the Act unless certain conditions are met, including, among other things, the existence of a public market
for the shares, the availability of certain current public information about the Company, the resale following the required holding
period under Rule 144 and the number of shares being sold during any three month period not exceeding specified limitations. Purchaser
is aware that the conditions for resale set forth in Rule 144 have not been satisfied and that the Company presently has no plans
to satisfy these conditions in the foreseeable future.

4.5             
Accredited Investor Status. The Purchaser is an “Accredited Investor” as
such term is defined in Rule 501 under the Act.

4.6             
Further Limitations on Disposition. Without in any way limiting the representations
set forth above, the Purchaser further agrees not to make any disposition of all or any portion of the Securities unless and until:

(a)               
There is then in effect a Registration Statement under the Act covering such proposed disposition
and such disposition is made in accordance with such Registration Statement; or

(b)              
The Purchaser shall have notified the Company of the proposed disposition and shall have furnished
the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by
the Company, such Purchaser shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company,
that such disposition will not require registration under the Act or any applicable state securities laws.

(c)               
Notwithstanding the provisions of paragraphs (a) and (b) above, no such registration
statement or opinion of counsel shall be necessary for a transfer by the Purchaser to (i) any shareholder, partner, retired partner,
member or former member of the Purchaser for no additional consideration, (ii) any affiliate, including affiliated funds, for no
additional consideration or (iii) transfers by gift, will or intestate succession to any spouse or lineal descendants or ancestors,
if all transferees agree in writing to be subject to the terms hereof to the same extent as if they were Purchasers hereunder.

5.                 
Default; Remedies.

5.1             
Each of the following shall constitute an event of default (each, an “Event of Default”)
under this Note:

    	 

    	 

    

(a)               
The Company shall fail to pay (i) when due any Principal Amount or Interest payment on
the due date hereunder or (ii) any other payment required under the terms of this Note on the date due and such payment shall
not have been made within five days of the Company’s receipt of the Purchaser’s written notice to the Company of such
failure to pay; 

(b)              
The Company shall fail to observe or perform any other covenant, obligation, condition or
agreement contained this Note and (i) such failure shall continue for 15 days, or (ii) if such failure is not curable
within such 15-day period, but is reasonably capable of cure within 30 days, either (A) such failure shall continue for 30
days or (B) the Company shall not have commenced a cure in a manner reasonably satisfactory to Purchaser within the initial
15-day period; or

(c)               
The Company files any petition or action for relief under any bankruptcy, reorganization,
insolvency or moratorium law or any other law for the relief of, or relating to, debtors, now or hereafter in effect, or makes
any general assignment for the benefit of creditors or takes any corporate action in furtherance of any of the foregoing;

(d)              
An involuntary petition is filed against the Company (unless such petition is dismissed or
discharged within thirty (30) days) under any bankruptcy statute now or hereafter in effect, or a custodian, receiver, trustee,
assignee for the benefit of creditors (or other similar official) is appointed to take possession, custody or control of any property
of the Company; or 

(e)               
The Company’s stockholders or board of directors affirmatively vote to liquidate, dissolve,
or wind up the Company or the Company otherwise ceases to carry on its ongoing business operations.

5.2             
Upon the occurrence and during the continuance of any Event of Default, all unpaid Principal
Amount on this Note, accrued and unpaid Interest thereon and all other amounts owing hereunder shall, at the option of the Purchaser,
and, upon the occurrence of any Event of Default pursuant to Sections 5.1 (c), (d) or (e) of this Note, automatically, be
immediately due, payable and collectible by Purchaser pursuant to applicable law. Purchaser shall have all rights and may exercise
all remedies available to it under law, successively or concurrently.

6.                 
Ranking. The Notes shall rank junior to all indebtedness of the Company existing
as of the Issuance Date.

7.                 
Prepayment. Prepayment of the outstanding Principal Amount plus accrued but
unpaid Interest may be made anytime without consent.

8.                 
Waiver; Payment Of Fees And Expenses. Company waives presentment and demand
for payment, notice of dishonor, protest and notice of protest of this Note, and shall pay all costs of collection when incurred,
including, without limitation, reasonable attorneys’ fees, costs and other expenses. The right to plead any and all statutes
of limitations as a defense to any demands hereunder is hereby waived to the full extent permitted by law. No delay by Purchaser
shall constitute a waiver, election or acquiescence by it.

9.                 
Transaction Fees and Expenses. The Company and the Purchaser shall pay their
own costs and expenses in connection with the preparation, execution and delivery of this Note and the other transaction documents.

10.             
Cumulative Remedies. Purchaser’s rights and remedies under this Note shall
be cumulative. Purchaser shall have all other rights and remedies not inconsistent herewith as provided under the UCC, by law or
in equity. No exercise by Purchaser of one right or remedy shall be deemed an election, and no waiver by Purchaser of any Event
of Default shall be deemed a continuing waiver of such Event of Default or the waiver of any other Event of Default.

11.             
Miscellaneous.

11.1         
Governing Law. The terms of this Note shall be construed in accordance with the laws
of the State of Minnesota, as applied to contracts entered into by Minnesota residents within the State of Minnesota, and to be
performed entirely within the State of Minnesota.

    	 

    	 

    

11.2         
Successors and Assigns; Assignment. The terms and conditions of this Note shall inure
to the benefit of and be binding upon the respective successors and assigns of the parties. Neither party may assign this Note
or delegate any of its rights or obligations hereunder without the written consent of the other party.

11.3         
Titles and Subtitles. The titles and subtitles used in this Note are used for convenience
only and are not to be considered in construing or interpreting the Note.

11.4         
Notices. All notices required or permitted hereunder shall be in writing and shall
be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) five (5) days after having been sent by
registered or certified mail, return receipt requested, postage prepaid, or (c) one (1) day after deposit with a nationally recognized
overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the
Purchaser at the address, facsimile number, or e-mail address set forth on the signature page hereto, or if to the Company, to
it at 7760 France Avenue South, 11th Floor, Minneapolis, MN 55435, Attn: William Cavanaugh, Facsimile: (888) 370-2819 (or to such
other address, facsimile number, or e-mail address as the Purchaser or the Company as a party may designate by notice the other
party) with a copy to Morgan, Lewis & Bockius LLP, 502 Carnegie Center, Princeton, NJ 08540, Attn: Emilio Ragosa, Esq., Facsimile:
(609) 919-6701.

11.5         
Amendment; Modification; Waiver. This Note (and the other Notes) may be amended, modified
or waived with the written consent of the Company and the holders of a majority of the outstanding principal amount of the Notes
(the “Requisite Purchasers”). Notwithstanding the foregoing, no amendment or waiver of any provision of any Notes (i)
shall be affected unless all Notes are treated similarly and not disproportionately, and (ii) shall not be binding on the Company
(unless consented to in writing by the Company) if such amendment or waiver would increase the financial obligations of the Company
under this Note (regardless of whether such amendment or waiver applies identically to all other Notes).

11.6         
Usury. In the event any Interest is paid on this Note which is deemed to be in excess
of the then legal maximum rate, then that portion of the Interest payment representing an amount in excess of the then legal maximum
rate shall be deemed a payment of the Principal Amount and applied against the Principal Amount of this Note.

11.7         
Counterparts. This Note may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument.

[SIGNATURE PAGE TO FOLLOW]

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Convertible Promissory Note as of the day and year first written above.

	PURCHASER	 	VERTICAL HEALTH SOLUTIONS, INC.
	 	 	 
	Signature	 	Signature
	 	 	
	Printed Name	 	Printed Name
	 	 	
	Address line 1	 	Title
	 	 
	Address line 2	 
	 	 
	Address line 2	 
	 	 
	Phone Number	 
	 	 
	Email Address	 

    	 

    	 

    

 

NOTICE OF CONVERSION

(To be executed by the Purchase in order to
convert the Note)

 

The undersigned hereby irrevocably elects to
convert as identified below the Convertible Promissory Note issued by Vertical Health Solutions, Inc. d/b/a OnPoint Medical Diagnostics
(the “Company”) into shares of Common Stock of the Company according to the conditions of conversion stated therein,
as of the Conversion Date written below:

 

Select One:

 

	 	All of the Principal and Interest accrued through the date of the conversion

 

	 	$ ___________________ of principle and accrued interest

 

 

 

Conversion Date: ____________________

 

 

	PURCHASER	 
	 	 
	Signature	 
	
         

         

        SHARES TO BE REGISTERED AND DELIVERED AS
        FOLLOWS:

         

         
	 
	Printed Name	 
	 	 
	Address Line 1	 
	 	 
	Address line 2	 
	 	 
	
        Address line 3

         

         
	 
	
        Phone number

         

         
	 
	Email address	 

    	 

    	 

    

EXHIBIT A

FORM OF WARRANT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]